Cantor Fitzgerald raised the firm's price target on CareTrust REIT to $42 from $37 and keeps a Neutral rating on the shares. While the company issued 2026 FFO guidance that narrowly missed consensus estimates for 2026, this should be easily recoverable over the course of the year, the analyst tells investors in a research note.
